Literature DB >> 19667048

Hag mediates adherence of Moraxella catarrhalis to ciliated human airway cells.

Rachel Balder1, Thomas M Krunkosky, Chi Q Nguyen, Lacey Feezel, Eric R Lafontaine.   

Abstract

Moraxella catarrhalis is a human pathogen causing otitis media in infants and respiratory infections in adults, particularly patients with chronic obstructive pulmonary disease. The surface protein Hag (also designated MID) has previously been shown to be a key adherence factor for several epithelial cell lines relevant to pathogenesis by M. catarrhalis, including NCIH292 lung cells, middle ear cells, and A549 type II pneumocytes. In this study, we demonstrate that Hag mediates adherence to air-liquid interface cultures of normal human bronchial epithelium (NHBE) exhibiting mucociliary activity. Immunofluorescent staining and laser scanning confocal microscopy experiments demonstrated that the M. catarrhalis wild-type isolates O35E, O12E, TTA37, V1171, and McGHS1 bind principally to ciliated NHBE cells and that their corresponding hag mutant strains no longer associate with cilia. The hag gene product of M. catarrhalis isolate O35E was expressed in the heterologous genetic background of a nonadherent Haemophilus influenzae strain, and quantitative assays revealed that the adherence of these recombinant bacteria to NHBE cultures was increased 27-fold. These experiments conclusively demonstrate that the hag gene product is responsible for the previously unidentified tropism of M. catarrhalis for ciliated NHBE cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19667048      PMCID: PMC2747927          DOI: 10.1128/IAI.00212-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  106 in total

Review 1.  Dynamics of nasopharyngeal colonization by potential respiratory pathogens.

Authors:  J A García-Rodríguez; M J Fresnadillo Martínez
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

Review 2.  Ciliary function and the role of cilia in clearance.

Authors:  Wendy Stannard; Chris O'Callaghan
Journal:  J Aerosol Med       Date:  2006

3.  CEACAM1 inhibits Toll-like receptor 2-triggered antibacterial responses of human pulmonary epithelial cells.

Authors:  Hortense Slevogt; Solveig Zabel; Bastian Opitz; Andreas Hocke; Julia Eitel; Philippe D N'guessan; Lothar Lucka; Kristian Riesbeck; Wolfgang Zimmermann; Janine Zweigner; Bettina Temmesfeld-Wollbrueck; Norbert Suttorp; Bernhard B Singer
Journal:  Nat Immunol       Date:  2008-10-05       Impact factor: 25.606

Review 4.  Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature.

Authors:  B J Currie; D A Fisher; D M Howard; J N Burrow; D Lo; S Selva-Nayagam; N M Anstey; S E Huffam; P L Snelling; P J Marks; D P Stephens; G D Lum; S P Jacups; V L Krause
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

5.  The Moraxella catarrhalis immunoglobulin D-binding protein MID has conserved sequences and is regulated by a mechanism corresponding to phase variation.

Authors:  Andrea Möllenkvist; Therése Nordström; Christer Halldén; Jens Jørgen Christensen; Arne Forsgren; Kristian Riesbeck
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

6.  Identification of a repressor of a truncated denitrification pathway in Moraxella catarrhalis.

Authors:  Wei Wang; Anthony R Richardson; Willm Martens-Habbena; David A Stahl; Ferric C Fang; Eric J Hansen
Journal:  J Bacteriol       Date:  2008-09-26       Impact factor: 3.490

7.  Moraxella catarrhalis binding to host cellular receptors is mediated by sequence-specific determinants not conserved among all UspA1 protein variants.

Authors:  Michael J Brooks; Jennifer L Sedillo; Nikki Wagner; Wei Wang; Ahmed S Attia; Henry Wong; Cassie A Laurence; Eric J Hansen; Scott D Gray-Owen
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

8.  Modular arrangement of allelic variants explains the divergence in Moraxella catarrhalis UspA protein function.

Authors:  Michael J Brooks; Jennifer L Sedillo; Nikki Wagner; Cassie A Laurence; Wei Wang; Ahmed S Attia; Eric J Hansen; Scott D Gray-Owen
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

9.  Clinical and laboratory aspects of Moraxella catarrhalis bacteremia in children.

Authors:  Ahmed Ahmed; Arnon Broides; Noga Givon-Lavi; Nehama Peled; Ron Dagan; David Greenberg
Journal:  Pediatr Infect Dis J       Date:  2008-05       Impact factor: 2.129

10.  Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era.

Authors:  Lise E Nigrovic; Nathan Kuppermann; Richard Malley
Journal:  Acad Emerg Med       Date:  2008-06       Impact factor: 3.451

View more
  22 in total

1.  Antibodies against In Vivo-Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei.

Authors:  Shawn M Zimmerman; Jeremy S Dyke; Tomislav P Jelesijevic; Frank Michel; Eric R Lafontaine; Robert J Hogan
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

Review 2.  Panel 5: Microbiology and immunology panel.

Authors:  Timothy F Murphy; Tasnee Chonmaitree; Stephen Barenkamp; Jennelle Kyd; Johanna Nokso-Koivisto; Janak A Patel; Terho Heikkinen; Noboru Yamanaka; Pearay Ogra; W Edward Swords; Tania Sih; Melinda M Pettigrew
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

3.  Transcriptional Response of Respiratory Epithelium to Nontuberculous Mycobacteria.

Authors:  Masashi Matsuyama; Andrew J Martins; Shamira Shallom; Olena Kamenyeva; Anuj Kashyap; Elizabeth P Sampaio; Juraj Kabat; Kenneth N Olivier; Adrian M Zelazny; John S Tsang; Steven M Holland
Journal:  Am J Respir Cell Mol Biol       Date:  2018-02       Impact factor: 6.914

4.  Persistence of Moraxella catarrhalis in Chronic Obstructive Pulmonary Disease and Regulation of the Hag/MID Adhesin.

Authors:  Timothy F Murphy; Aimee L Brauer; Melinda M Pettigrew; Eric R LaFontaine; Hervé Tettelin
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

Review 5.  Cilia dysfunction in lung disease.

Authors:  Ann E Tilley; Matthew S Walters; Renat Shaykhiev; Ronald G Crystal
Journal:  Annu Rev Physiol       Date:  2014-10-29       Impact factor: 19.318

Review 6.  Panel 6: Vaccines.

Authors:  Stephen I Pelton; Melinda M Pettigrew; Stephen J Barenkamp; Fabrice Godfroid; Carlos G Grijalva; Amanda Leach; Janak Patel; Timothy F Murphy; Sanja Selak; Lauren O Bakaletz
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

7.  The first engagement of partners in the Euprymna scolopes-Vibrio fischeri symbiosis is a two-step process initiated by a few environmental symbiont cells.

Authors:  Melissa A Altura; Elizabeth A C Heath-Heckman; Amani Gillette; Natacha Kremer; Anne-Marie Krachler; Caitlin Brennan; Edward G Ruby; Kim Orth; Margaret J McFall-Ngai
Journal:  Environ Microbiol       Date:  2013-07-03       Impact factor: 5.491

8.  Moraxella catarrhalis uses a twin-arginine translocation system to secrete the β-lactamase BRO-2.

Authors:  Rachel Balder; Teresa L Shaffer; Eric R Lafontaine
Journal:  BMC Microbiol       Date:  2013-06-19       Impact factor: 3.605

9.  Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2.

Authors:  Teresa L Shaffer; Rachel Balder; Sean W Buskirk; Robert J Hogan; Eric R Lafontaine
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

10.  Comprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance model.

Authors:  Margarita Smidt; Patrick Bättig; Suzanne J C Verhaegh; Axel Niebisch; Markus Hanner; Sanja Selak; Wolfgang Schüler; Eva Morfeldt; Christel Hellberg; Eszter Nagy; Urban Lundberg; John P Hays; Andreas Meinke; Birgitta Henriques-Normark
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.